Top Hedge Fund News, Member Posts, Hedge Fund Daily Indices and more!

2yrs ago Hedge Fund hedgeweek Views: 363

CME Group International ADV up to 5.1 million contracts in Q2 2021

Submitted 13/07/2021 - 12:49pm

CME Group's international average daily volume (ADV) reached 5.1 million contracts in Q2 2021, up 6 per cent year on year. 

Reflecting all trading done outside North America, this volume was driven by global growth in Agricultural and Interest Rate products, up 30 per cent and 42 per cent respectively. Agricultural products also established record quarterly volumes in Europe, Middle East and Africa (EMEA), as well as Asia Pacific and Latin America. 

“In the second quarter of this year, we saw strong interest across our international client base, especially in our Agricultural products which established record quarterly volumes,” says William Knottenbelt, Senior Managing Director and Head of International, CME Group. “We are committed to continuing to provide a robust, liquid and regulated marketplace for clients to manage their risk around the clock and around the world.” 

In Q2 2021, EMEA ADV hit 3.7 million contracts, up 5 per cent from Q2 2020. This was due to a strong performance in Agricultural and Interest Rate products in the region, up 35 per cent and 24 per cent respectively, compared to the same period in 2020.   

Asia Pacific Q2 2021 ADV hit 1.2 million contracts, up 8 per cent from Q2 2020. This was driven by a 67 per cent growth in Agricultural products, and 60 per cent growth in Interest Rate products in the region. 
  
Latin America ADV was 114,000 contracts in Q2 2021, up 5 per cent from the corresponding period in 2020. This was led by 41 per cent growth in Agricultural products and 14 per cent growth in FX products in the region.   
 
Globally, CME Group reported ADV of 18.4 million contracts during Q2 2021, up 5 per cent from the same period last year. This was led by Interest Rate products, up 25 per cent, and Agricultural products, up 24 per cent.   
 

Like this article? Sign up to our free newsletter Related Topics Markets Trading & Execution

Today's Hedge Fund Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.